Exosomes – tiny biological nanoparticles which transfer information between cells – offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.
Areas which could benefit include cancer treatment and regenerative medicine, say Dr Steven Conlan from Swansea University, Dr Mauro Ferrari of Houston Methodist Research Institute in Texas, and Dr Inês Mendes Pinto from the International Iberian Nanotechnology Laboratory in Portugal. Their commissioned paper, Exosomes as Reconfigurable Therapeutic Systems, is published today by Cell Press in Trends in Molecular Medicine.
Exosomes are particles produced by all cells in the body and are from 30-130 nanometres in size – a nanometre is one-billionth of a metre. They act as biological signalling systems, communicating between cells, carrying proteins, lipids, DNA and RNA. They drive biological processes, from modulating gene expression to transmitting information through breast milk.
Though discovered in 1983, the full potential of exosomes is only gradually being revealed. The researchers show that the nanoparticles’ possible medical benefits fall into three broad categories:
- Detecting disease – by acting as disease-specific biomarkers
- Activating immune responses to boost immunity
- Treating diseases – serving as the vehicle for drugs, for example bearing cancer therapies as their payload, to target tumours
One of the most useful properties of exosomes is that they are able to cross barriers such as the plasma membrane of cells, or the blood/brain barrier. This makes them well-suited to delivering therapeutic molecules in a very targeted way.
The potential benefits of exosomes can be seen in the wide range of research projects – cited in the paper – already either completed or under way, in areas such as:
- Improved testing for prostate cancer
- A small-cell lung cancer trial
- Stem cell-derived exosomes strengthening heart muscles
- Regeneration of muscle and tissue
The team caution that there is more to do before research into exosomes translates into new techniques and treatments. Side-effects need to be considered, and a standardised approach to isolating, characterising and storing exosomes will need to be developed.
Researchers will also need to ensure that the properties of exosomes do not end up causing harm: for example they can transfer drug resistance and pacify the immune system.
Nevertheless, the potential is very clear, with the team describing exosomes as “increasingly promising”.
Professor Steve Conlan of Swansea University Medical School, one of the authors of the paper, said:
“Our survey of research into exosomes shows clearly that they offer enormous potential as a basis for detecting and treating disease.
Further studies are necessary to turn this research into clinical outcomes, but researchers and funders should be very encouraged by our findings. Our own research in Swansea is investigating the use of exosomes and exosome-like synthetic nanoparticles in combatting ovarian and endometrial cancer.
Progress in this field depends on partnership. As the authorship of our own paper illustrates, researchers in different countries are increasingly working together in nanohealth. Swansea University has wider links with Houston and Portuguese based researchers in the field.
It’s also important to build partnerships outside academia, in particular with government and companies in this fast-growing sector.”
The Latest on: Exosomes
- Driven by EXOSOMES, Powered by PEPTIDES, GROWTH FACTORS, DNA REPAIR EMZYMES™on November 29, 2019 at 8:13 am
Scottsdale, AZ -- (ReleaseWire) -- 11/29/2019 -- hMSC Skincare introduces powerhouse formulations featuring innovative, clinically validated ingredients utilizing human Hybrid Mesenchymal Stem Cell ...
- Driven by EXOSOMES, Powered by PEPTIDES, GROWTH FACTORS, CYTOKINES, DNA REPAIR ENZYMES™on November 26, 2019 at 4:09 pm
A Curated Team of Best in Class Biotech Chemists & World Renown Cosmetic Formulators, Led by Veteran Aesthetic Industry Experts. SCOTTSDALE, Ariz., Nov. 26, 2019 /PRNewswire/ -- hMSC Skincare ...
- Driven by EXOSOMES, Powered by PEPTIDES, GROWTH FACTORS, CYTOKINES, DNA REPAIR ENZYMESZ™on November 26, 2019 at 4:38 am
SCOTTSDALE, Ariz., Nov. 26, 2019 /PRNewswire/ -- hMSC Skincare introduces powerhouse formulations featuring innovative, clinically validated ingredients utilizing human Hybrid Mesenchymal Stem Cell ...
- Aruna Bio to Present at the 31st Annual Piper Jaffray Healthcare Conferenceon November 21, 2019 at 3:01 am
Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark Sirgo, Chief Executive Officer, and Dr. Steve Stice, ...
- Targeted delivery of lysosomal enzymes to the endocytic compartment in human cells using engineered extracellular vesicleson November 21, 2019 at 2:18 am
Gaucher disease is one of the most common types of LSDs caused by mutations to the lysosomal β-glucocerebrosidase (GBA). Here, we describe a genetic strategy to produce engineered exosomes loaded with ...
- Mechanisms of nuclear content loading to exosomeson November 20, 2019 at 11:30 am
1 Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. 2 Department of Medicine, Stanford University, Stanford, CA, USA. 3 ...
- Using 'Trojan horses' to kill tumor cells from withinon November 19, 2019 at 11:49 am
The researchers have used exosomes as "Trojan horses" to deliver palladium (Pd) catalysts into cancer cells. "We introduce the catalyst into tiny vesicles or exosomes the size of about 100 nanometres, ...
- Global exosomes market is expected to grow with a CAGR of 17.5% over the forecast period from 2019-2025on November 18, 2019 at 6:32 am
New York, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Exosomes Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" - https ...
- The exosomes market is expected to register a CAGR of nearly 18.0% during the forecast period, 2019on November 11, 2019 at 11:22 am
The exosomes market is expected to register a CAGR of nearly 18.0% during the forecast period, 2019-2024. Read the full report: https://www.reportlinker.com/p05826220 ...
- Spherical exosomes may deliver what an injured kidney needson November 7, 2019 at 8:15 am
Like the construction workers, scientists suspect these spheres, called exosomes, are there to repair damage and restore function, and now want to learn more about what they are doing and the cargo ...
via Google News and Bing News